These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 19086352)
1. Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the DEDICOM survey. Kumar A; Nagpal J; Bhartia A J Assoc Physicians India; 2008 Sep; 56():667-74. PubMed ID: 19086352 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk profile of subjects with known diabetes from the middle- and high-income group population of Delhi: the DEDICOM survey. Nagpal J; Bhartia A Diabet Med; 2008 Jan; 25(1):27-36. PubMed ID: 18028441 [TBL] [Abstract][Full Text] [Related]
3. Increasing expenditure on health care incurred by diabetic subjects in a developing country: a study from India. Ramachandran A; Ramachandran S; Snehalatha C; Augustine C; Murugesan N; Viswanathan V; Kapur A; Williams R Diabetes Care; 2007 Feb; 30(2):252-6. PubMed ID: 17259490 [TBL] [Abstract][Full Text] [Related]
4. Cost of ambulatory care of diabetes mellitus: a study from north India. Grover S; Avasthi A; Bhansali A; Chakrabarti S; Kulhara P Postgrad Med J; 2005 Jun; 81(956):391-5. PubMed ID: 15937206 [TBL] [Abstract][Full Text] [Related]
5. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)]. Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091 [TBL] [Abstract][Full Text] [Related]
6. Out-of-pocket direct cost of ambulatory care of type 2 diabetes in Delhi: Estimates from the Delhi diabetes community-II (DEDICOM-II) survey. Rawat S; Bansal N; Yadav R; Goyal S; Nagpal J Diabetes Metab Syndr; 2024 Jul; 18(7):103089. PubMed ID: 39126763 [TBL] [Abstract][Full Text] [Related]
7. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes. Mody R; Kalsekar I; Kavookjian J; Iyer S; Rajagopalan R; Pawar V J Diabetes Complications; 2007; 21(2):75-83. PubMed ID: 17331855 [TBL] [Abstract][Full Text] [Related]
8. Cost of medical care among type 2 diabetic patients with a co-morbid condition--hypertension in India. Tharkar S; Satyavani K; Viswanathan V Diabetes Res Clin Pract; 2009 Feb; 83(2):263-7. PubMed ID: 19118912 [TBL] [Abstract][Full Text] [Related]
9. The cost of treating type 2 diabetes (CODEIRE). Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175 [TBL] [Abstract][Full Text] [Related]
10. Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study. Liebl A; Breitscheidel L; Nicolay C; Happich M Curr Med Res Opin; 2008 Aug; 24(8):2349-58. PubMed ID: 18606055 [TBL] [Abstract][Full Text] [Related]
11. The personal costs of diabetes: a significant barrier to care in South Auckland. Simmons D; Peng A; Cecil A; Gatland B N Z Med J; 1999 Oct; 112(1097):383-5. PubMed ID: 10587070 [TBL] [Abstract][Full Text] [Related]
12. Identifying factors that affect patients' willingness to pay for inhaled insulin. Pinto SL; Holiday-Goodman M; Black CD; Lesch D Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826 [TBL] [Abstract][Full Text] [Related]
13. Time and cost involved in the care of newly registered patients with diabetes mellitus and other lifestyle diseases at diabetes clinics in Japan (JDDM 4). Oishi M; Yokoyama H; Abe N; Iwasaki K; Okuguchi F; Kawai K; Sugimoto H; Takamura H; Takeda H; Doi K; Hirao K; Ikeda S Diabet Med; 2007 Oct; 24(10):1149-55. PubMed ID: 17888135 [TBL] [Abstract][Full Text] [Related]
14. The level and determinants of diabetes knowledge in Kuwaiti adults with type 2 diabetes. Al-Adsani AM; Moussa MA; Al-Jasem LI; Abdella NA; Al-Hamad NM Diabetes Metab; 2009 Apr; 35(2):121-8. PubMed ID: 19250850 [TBL] [Abstract][Full Text] [Related]
15. Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study. Schöffski O; Breitscheidel L; Benter U; Dippel FW; Müller M; Volk M; Pfohl M J Med Econ; 2008; 11(4):695-712. PubMed ID: 19450076 [TBL] [Abstract][Full Text] [Related]
16. Foot care economics--cost burden to diabetic patients with foot complications: a study from southern India. Shobhana R; Rao PR; Lavanya A; Vijay V; Ramachandran A J Assoc Physicians India; 2001 May; 49():530-3. PubMed ID: 11361267 [TBL] [Abstract][Full Text] [Related]
17. Cost of care of schizophrenia: a study of Indian out-patient attenders. Grover S; Avasthi A; Chakrabarti S; Bhansali A; Kulhara P Acta Psychiatr Scand; 2005 Jul; 112(1):54-63. PubMed ID: 15952946 [TBL] [Abstract][Full Text] [Related]
18. Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient cost. Athanasakis K; Ollandezos M; Angeli A; Gregoriou A; Geitona M; Kyriopoulos J Diabet Med; 2010 Jun; 27(6):679-84. PubMed ID: 20546287 [TBL] [Abstract][Full Text] [Related]
19. Economic burden on families of childhood type 1 diabetes in urban Sudan. Elrayah H; Eltom M; Bedri A; Belal A; Rosling H; Ostenson CG Diabetes Res Clin Pract; 2005 Nov; 70(2):159-65. PubMed ID: 15919129 [TBL] [Abstract][Full Text] [Related]
20. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data. Ringborg A; Martinell M; Stålhammar J; Yin DD; Lindgren P Int J Clin Pract; 2008 May; 62(5):708-16. PubMed ID: 18355236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]